| The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma Nature genetics 46 (5), 444-450, 2014 | 1041 | 2014 |
| Novel mutations target distinct subgroups of medulloblastoma G Robinson, M Parker, TA Kranenburg, C Lu, X Chen, L Ding, TN Phoenix, ... Nature 488 (7409), 43-48, 2012 | 929 | 2012 |
| Vismodegib exerts targeted efficacy against recurrent sonic hedgehog–subgroup medulloblastoma: results from phase II pediatric brain tumor consortium studies PBTC-025B and PBTC-032 GW Robinson, BA Orr, G Wu, S Gururangan, T Lin, I Qaddoumi, ... Journal of Clinical Oncology 33 (24), 2646-2654, 2015 | 463 | 2015 |
| Diagnostic accuracy of conventional and cholangioscopy-guided sampling of indeterminate biliary lesions at the time of ERCP: a prospective, long-term follow-up study PV Draganov, S Chauhan, MS Wagh, AR Gupte, T Lin, W Hou, ... Gastrointestinal endoscopy 75 (2), 347-353, 2012 | 361* | 2012 |
| Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition T Lin, A Ponn, X Hu, BK Law, J Lu Oncogene 29 (35), 4896-4904, 2010 | 347 | 2010 |
| Histone H3. 3 K27M accelerates spontaneous brainstem glioma and drives restricted changes in bivalent gene expression JD Larson, LH Kasper, BS Paugh, H Jin, G Wu, CH Kwon, Y Fan, TI Shaw, ... Cancer cell 35 (1), 140-155. e7, 2019 | 247 | 2019 |
| Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas KW Pajtler, J Wen, M Sill, T Lin, W Orisme, B Tang, JM Hübner, ... Acta neuropathologica 136, 211-226, 2018 | 234 | 2018 |
| Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis V Ramaswamy, T Hielscher, SC Mack, A Lassaletta, T Lin, KW Pajtler, ... Journal of clinical oncology 34 (21), 2468-2477, 2016 | 192 | 2016 |
| Outcomes by clinical and molecular features in children with medulloblastoma treated with risk-adapted therapy: results of an international phase III trial (SJMB03) A Gajjar, GW Robinson, KS Smith, T Lin, TE Merchant, M Chintagumpala, ... Journal of Clinical Oncology 39 (7), 822-835, 2021 | 145 | 2021 |
| Microbiological characterization in children with Aggressive Periodontitis LM Shaddox, H Huang, T Lin, W Hou, PL Harrison, I Aukhil, CB Walker, ... Journal of Dental Research 91 (10), 927-933, 2012 | 137 | 2012 |
| Regulation of glycolysis and the Warburg effect by estrogen-related receptors Q Cai, T Lin, S Kamarajugadda, J Lu Oncogene, 2012 | 118 | 2012 |
| Heterogeneity within the PF-EPN-B ependymoma subgroup FMG Cavalli, JM Hübner, T Sharma, B Luu, M Sill, M Zapotocky, SC Mack, ... Acta neuropathologica 136, 227-237, 2018 | 102 | 2018 |
| A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium … R Salloum, TR Hummel, SS Kumar, K Dorris, S Li, T Lin, VM Daryani, ... Journal of neuro-oncology 129, 443-451, 2016 | 98 | 2016 |
| Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children C Wetmore, J Boyett, S Li, T Lin, A Bendel, A Gajjar, BA Orr Neuro-oncology 17 (6), 882-888, 2015 | 89 | 2015 |
| Serial assessment of measurable residual disease in medulloblastoma liquid biopsies APY Liu, KS Smith, R Kumar, L Paul, L Bihannic, T Lin, KK Maass, ... Cancer cell 39 (11), 1519-1530. e4, 2021 | 88 | 2021 |
| A phase I trial of imetelstat in children with refractory or recurrent solid tumors: a Children's Oncology Group Phase I Consortium Study (ADVL1112) PA Thompson, R Drissi, JA Muscal, E Panditharatna, M Fouladi, AM Ingle, ... Clinical Cancer Research 19 (23), 6578-6584, 2013 | 84 | 2013 |
| FBXO11 promotes ubiquitination of the Snail family of transcription factors in cancer progression and epidermal development Y Jin, AK Shenoy, S Doernberg, H Chen, H Luo, H Shen, T Lin, M Tarrash, ... Cancer letters 362 (1), 70-82, 2015 | 81 | 2015 |
| Reirradiation of recurrent medulloblastoma: does clinical benefit outweigh risk for toxicity? C Wetmore, D Herington, T Lin, A Onar‐Thomas, A Gajjar, TE Merchant Cancer 120 (23), 3731-3737, 2014 | 81 | 2014 |
| Effect of μ-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population D Zhang, C Shao, M Shao, P Yan, Y Wang, Y Liu, W Liu, T Lin, Y Xie, ... Biological psychiatry 61 (11), 1244-1251, 2007 | 74 | 2007 |
| Clinical outcomes and patient-matched molecular composition of relapsed medulloblastoma R Kumar, KS Smith, M Deng, C Terhune, GW Robinson, BA Orr, APY Liu, ... Journal of Clinical Oncology 39 (7), 807-821, 2021 | 72 | 2021 |
